Status:

TERMINATED

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Human Immunodeficiency Virus I Infection

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The FXReservoir#1 study (NCT03618862) showed that certain FXR ligands reactivate latent viruses in the reservoir circulating in all HIV+ patients tested. These molecules appear as latency reversal age...

Eligibility Criteria

Inclusion

  • Criteria relating to the population studied: patients aged 18 to 65 years old, men or women, regardless of ethnic origin.
  • Nosological criteria: HIV-1 infection, documented by a complete western blot and/or a detectable viral load at the time of diagnosis, regardless of the viral subtype.
  • Pathology severity and progression criteria: patients with a CD4+ count greater than 500 elements/mm3 at the last follow-up visit prior to inclusion in the study. Undetectable viral load for at least six months on stable treatment.
  • Criteria relating to treatments/strategies/procedures: Current cART treatment mandatory, regardless of the combination of anti-retrovirals, effective with undetectable viral load. The number of processing lines is not limited.
  • Criteria relating to regulation: Absence of opposition

Exclusion

  • Criteria relating to the population studied: pregnant or breastfeeding women
  • Criteria relating to contraindications to the protocol explorations:
  • Acute or chronic anaemias Acute infections, fever Coagulation disorders, patients taking anticoagulants
  • \- Criteria relating to regulation: Subjects placed under judicial safeguard, guardianship or curatorship Subjects participating in another research with an ongoing exclusion period.

Key Trial Info

Start Date :

April 12 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 22 2022

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT05219916

Start Date

April 12 2022

End Date

July 22 2022

Last Update

March 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Service des maladies infectieuses et tropicales Hôpital de la Croix Rousse

Lyon, France, 69004

Selection of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent HIV Proviruses | DecenTrialz